Catalyst Capital Advisors LLC Elanco Animal Health Inc Transaction History
Catalyst Capital Advisors LLC
- $4.3 Billion
- Q2 2024
A detailed history of Catalyst Capital Advisors LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 572 shares of ELAN stock, worth $8,191. This represents 0.0% of its overall portfolio holdings.
Number of Shares
572
Previous 729
21.54%
Holding current value
$8,191
Previous $11,000
27.27%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ELAN
# of Institutions
447Shares Held
478MCall Options Held
3.1MPut Options Held
1.26M-
Dodge & Cox San Francisco, CA83.6MShares$1.2 Billion0.76% of portfolio
-
Primecap Management CO Pasadena, CA52.8MShares$756 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.4MShares$708 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD28.1MShares$402 Million0.05% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$334 Million0.01% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.79B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...